---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002702"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T22:08:52.545311+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech enters ATM offering agreement for up to $3M common stock

## Summary
- Entered Equity Distribution Agreement with Maxim Group LLC for at-the-market offering of up to $3M common stock.
- Currently limited to selling $663,329 due to Form S-3 General Instruction I.B.6; registration statement not yet effective.
- Maxim receives 3.0% commission on gross proceeds; expense reimbursement up to $50,000 initial, $5,000 quarterly.
- Net proceeds to be used for working capital and general corporate purposes.
- Agreement may be terminated by either party on 15 days' notice or after 24 months.

## SEC filing metadata
- accession: 0001641172-25-002702
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000164117225002702/0001641172-25-002702-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000164117225002702/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002702
- JSON: https://secwatch.observer/filing/0001641172-25-002702.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002702.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.